[1] |
Kozhamkulov U, Akhmetova A, Rakhimova S, et al. Drug resistance detection and genotyping of M.tuberculosis from new pulmonary TB cases in kazakhstan. Chest, 2020, 157(6): A94. doi: 10.1016/j.chest.2020.05.104.
doi: 10.1016/j.chest.2020.05.104
URL
|
[2] |
Pigrau-Serrallach C, Rodríguez-Pardo D. Bone and joint tuberculosis. Eur Spine J, 2013, 22 Suppl 4:556-566. doi: 10.1007/s00586-012-2331-y.
doi: 10.1007/s00586-012-2331-y
pmid: 22711012
|
[3] |
Cheung WY, Luk KD. Clinical and radiological outcomes after conservative treatment of TB spondylitis: is the 15 years’ follow-up in the MRC study long enough? Eur Spine J, 2013, 22 Suppl 4:594-602. doi: 10.1007/s00586-012-2332-x.
doi: 10.1007/s00586-012-2332-x
pmid: 22565800
|
[4] |
Jin W, Wang Q, Wang Z, et al. Complete debridement for treatment of thoracolumbar spinal tuberculosis: a clinical curative effect observation. Spine J, 2014, 14(6):964-970. doi: 10.1016/j.spinee.2013.07.466.
doi: 10.1016/j.spinee.2013.07.466
URL
|
[5] |
Dunn RN, Ben Husien M. Spinal tuberculosis: review of current management. Bone Joint J, 2018, 100-b(4):425-431. doi: 10.1302/0301-620x.100b4.Bjj-2017-1040.R1.
doi: 10.1302/0301-620X.100B4.BJJ-2017-1040.R1
pmid: 29629596
|
[6] |
Wang B, Gao W, Hao D. Current Study of the Detection and Treatment Targets of Spinal Tuberculosis. Curr Drug Targets, 2020, 21(4):320-327. doi: 10.2174/1389450120666 191002151637.
doi: 10.2174/1389450120666 191002151637
URL
|
[7] |
Yong LN, Ahmedy F, Yin KN, et al. Functional Outcomes in Spinal Tuberculosis: A Review of the Literature. Asian Spine J, 2021, 15(3):381-391. doi: 10.31616/asj.2020.0086.
doi: 10.31616/asj.2020.0086
URL
|
[8] |
Hajiaheman Y, Yang Y, Shayilanbieke N, et al. Mycobacterium culturing and drug resistance of osteoarticular tuberculosis in Xinjiang, China. Medicine, 2020, 99(16):e19697. doi: 10.1097/md.0000000000019697.
doi: 10.1097/md.0000000000019697
URL
|
[9] |
Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med, 2012, 366(23):2161-2170. doi: 10.1056/NEJMoa1108789.
doi: 10.1056/NEJMoa1108789
URL
|
[10] |
Qian J, Rijiepu A, Zhu B, et al. Outcomes of radical debridement versus no debridement for the treatment of thoracic and lumbar spinal tuberculosis. Int Orthop, 2016, 40(10):2081-2088. doi: 10.1007/s00264-016-3234-z.
doi: 10.1007/s00264-016-3234-z
pmid: 27271724
|
[11] |
Yang P, Zang Q, Kang J, et al. Comparison of clinical efficacy and safety among three surgical approaches for the treatment of spinal tuberculosis: a meta-analysis. Eur Spine J, 2016, 25(12):3862-3874. doi: 10.1007/s00586-016-4546-9.
doi: 10.1007/s00586-016-4546-9
URL
|
[12] |
中国防痨协会基础专业委员会. 结核病诊断实验室检验规程. 北京: 中国教育文化出版社, 2006.
|
[13] |
Kim H, Kim SH, Shim TS, et al. Differentiation of Mycobacterium species by analysis of the heat-shock protein 65 gene (hsp65). Int J Syst Evol Microbiol, 2005, 55 Pt 4: 1649-1656. doi: 10.1099/ijs.0.63553-0.
doi: 10.1099/ijs.0.63553-0
|
[14] |
Turenne C, Chedore P, Wolfe J, et al. Mycobacterium lacus sp.nov., a novel slowly growing, non-chromogenic clinical isolate. Int J Syst Evol Microbiol, 2002, 52 Pt 6: 2135-2140. doi: 10.1099/00207713-52-6-2135.
doi: 10.1099/00207713-52-6-2135
|
[15] |
Turenne CY, Tschetter L, Wolfe J, et al. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol, 2001, 39(10):3637-3648. doi: 10.1128/jcm.39.10.3638-3648.2001.
doi: 10.1128/jcm.39.10.3638-3648.2001
pmid: 11574585
|
[16] |
上海市感染性疾病临床医学研究中心/同济大学附属上海市肺科医院, 首都医科大学附属北京胸科医院/北京市结核胸部肿瘤研究所, 中国防痨协会《中国防痨杂志》编辑委员会. 复治肺结核病诊断和治疗专家共识. 中国防痨杂志, 2021, 43(12):1226-1238. doi: 10.3969/j.issn.1000-6621.2021.12.002.
doi: 10.3969/j.issn.1000-6621.2021.12.002
|
[17] |
Liu Z, Wang J, Chen GZ, et al. Clinical Characteristics of 1378 Inpatients with Spinal Tuberculosis in General Hospitals in South-Central China. Biomed Res Int, 2019, 2019: 9765253. doi: 10.1155/2019/9765253.
doi: 10.1155/2019/9765253
|
[18] |
Zeng H, Shen X, Luo C, et al. 360-degree cervical spinal arthrodesis for treatment of pediatric cervical spinal tuberculosis with kyphosis. BMC Musculoskelet Disord, 2016, 17:175. doi: 10.1186/s12891-016-1034-7.
doi: 10.1186/s12891-016-1034-7
URL
|
[19] |
Merza MA, Farnia P, Tabarsi P, et al. Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis. J Infect Dev Ctries, 2011, 5(7):511-519. doi: 10.3855/jidc.1259.
doi: 10.3855/jidc.1259
URL
|
[20] |
夏玉朝, 李爽, 周淑娟, 等. 利福霉素钠与利福平治疗肺结核安全性评价. 安徽医药, 2018, 22(8):1582-1584. doi: 10.3969/j.issn.1009-6469.2018.08.045.
doi: 10.3969/j.issn.1009-6469.2018.08.045
|
[21] |
代晓琦, 李仁忠, 阮云洲, 等. 异烟肼对利福平单耐/多耐药肺结核患者治疗效果的分析. 中国防痨杂志, 2018, 40(6):564-569. doi: 10.3969/j.issn.1000-6621.2018.06.004.
doi: 10.3969/j.issn.1000-6621.2018.06.004
|
[22] |
Ding P, Li X, Jia Z, et al. Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis. BMC Infect Dis, 2017, 17(1):57. doi: 10.1186/s12879-016-2151-5.
doi: 10.1186/s12879-016-2151-5
URL
|
[23] |
Yao Y, Song W, Wang K, et al. Features of 921 Patients With Spinal Tuberculosis: A 16-Year Investigation of a General Hospital in Southwest China. Orthopedics, 2017, 40(6):e1017-e1023. doi: 10.3928/01477447-20171012-03.
doi: 10.3928/01477447-20171012-03
|
[24] |
谢永燃, 蓝珂. 利福喷丁对初治菌阳肺结核强化期阴转率的影响. 解放军预防医学杂志, 2019, 37(4):27-28. doi: CNKI:SUN:JYYX.0.2019-04-014.
doi: CNKI:SUN:JYYX.0
|
[25] |
林立敏, 叶寒辉. 利福霉素类药物治疗结核病的临床应用研究进展. 药物评价研究, 2020, 43(11):2335-2339. doi: 10.7501/j.issn.1674-6376.2020.11.032.
doi: 10.7501/j.issn.1674-6376.2020.11.032
|
[26] |
Lehloenya RJ, Dlamini S, Muloiwa R, et al. Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients. Open Forum Infect Dis, 2016, 3(3):ofw130. doi: 10.1093/ofid/ofw130.
doi: 10.1093/ofid/ofw130
URL
|
[27] |
Yang S, Yu Y, Ji Y, et al. Multi-drug resistant spinal tuberculosis-epidemiological characteristics of in-patients: a multicentre retrospective study. Epidemiol Infect, 2020, 148(11):e11. doi: 10.1017/s0950268820000011.
doi: 10.1017/s0950268820000011
URL
|